Company fully deploys 2019 work
Release time:
2020-07-30
News from our newspaper 1# April 28 , the group company held a business analysis meeting to review and summarize the work situation in 2018 , arrange and deploy the work for the new year, and put forward the work requirements. At the
meeting, various professional companies and directly affiliated enterprises made a report on the overall work situation of 2018 , focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and a work plan for 2019 . Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the internal control, safety and environmental protection work in 2018 . Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of each subordinate enterprise. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, General Manager of
Group Company, made a comprehensive review of the company's operation in 2018 and made a comparative analysis of the main economic indicators of each industrial sector. 2018 , the company's operating indicators in all industrial sectors have improved significantly year-on-year, and the group company has also created the best operating performance in history. All units have completed the formulation of the second round of "three-year business plan", which points out the direction for the next three years of business work; the group company has also completed the first draft of the new "five-year strategic development plan", which is being revised and enriched. In addition, the two major businesses have also made substantial progress in investment expansion and industrial integration around strategic goals, and the operating costs of major companies have decreased to varying degrees; the optimization of organizational structure and job settings has achieved new results, and management Efficiency and per capita labor productivity have been further improved; the level of information management has been further improved; new achievements have also been made in new product research and development, patent declaration, technological transformation and innovation. While affirming these achievements, Yu Jianhong also pointed out that some of the work was not completed as planned, and there was a large gap between the main business scale, management level, and innovation capabilities with advanced enterprises.
After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed the benefit targets of various professional companies and directly affiliated enterprises in 2019 , and put forward unified understanding, unified concept and unified action. Around strategic planning, grasp strategic opportunities and accelerate enterprise development; Further consolidate basic management, strengthen management innovation and improve operation efficiency; Improve product quality awareness, improve the technical level of process equipment, strengthen process quality control, and achieve high-quality growth; adhere to technological leadership, strengthen technological innovation, and increase R & D investment; improve talent training, introduction, and appointment mechanisms, and strengthen the construction of talent teams; grasp safety and environmental protection management; Further strengthen marketing management, comprehensively improve marketing capabilities; further strengthen corporate culture construction and other key tasks. Yu Jianhong stressed that at present, the environment and policies are in a changeable period, and the downward pressure on the development of the real economy is still increasing. Although the company's operating performance has improved steadily in recent years, it seems that it has not been affected, but it still feels the same at many levels. In this situation, only by taking the heart as the foundation, respecting the law and acting according to the essence of the market, can we find the correct foothold and starting point of the enterprise and find the correct development direction of the enterprise. Therefore, managers at all levels must insist on running conscientious enterprises and making conscientious products, that is, enterprises that make good use of resources and contribute to society, and manufacture products that can meet users' high-quality production and life needs; at the same time, increase innovation and continue to serve society Create new value. Only in this way can we better meet the needs of social development and usher in the spring of enterprise development. (this newspaper reporter)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page